Agoraphobia

vs. Panic disorder

Coded separately. Panic disorder centers on recurrent unexpected panic attacks plus persistent worry; agoraphobia centers on avoidance of specific situations. Many patients have both; either can exist without the other.

vs. Specific phobia (situational type)

Specific phobia targets ONE situation (flying, elevators, bridges); agoraphobia requires fear of TWO OR MORE of the five agoraphobic situation types. Single-situation phobias generally respond well to targeted exposure and are less functionally impairing.

vs. Social anxiety disorder

Social anxiety centers on fear of judgment; agoraphobia centers on fear of being unable to escape or get help. Patient may avoid crowds in both, but the fear content differs. Distinguishing matters for cognitive interventions.

vs. PTSD with avoidance

PTSD avoidance is trigger-specific (avoidance of trauma reminders); agoraphobic avoidance is situation-class specific (any enclosed space, any open space). Patient with combat PTSD avoiding crowded indoor spaces because they remind of vulnerable patrol settings is PTSD avoidance, not agoraphobia. Both can co-occur.

Graduated in vivo exposure (CBT)

Gold-standard psychotherapy. Build a hierarchy of feared agoraphobic situations from mildest (walking to mailbox alone) to most challenging (using public transit across the city). Systematically practice each level until anxiety attenuates, then move to next. Therapist-accompanied exposure for severely impaired patients early in treatment, transitioning to independent practice. 12-16 sessions typical; many patients need maintenance work for years.

SSRIs (paroxetine, sertraline, escitalopram)

First-line pharmacotherapy, particularly in agoraphobia comorbid with panic disorder. Reduces panic frequency and intensity, which in turn reduces anticipatory anxiety and enables exposure work. Same start-low principle as in panic disorder (half-dose initially). Onset 4-8 weeks; full benefit at 12 weeks.

SNRIs (venlafaxine XR)

Second-line pharmacotherapy with effect sizes comparable to SSRIs. Useful when SSRI trials fail or in patients with comorbid depression with prominent fatigue. Standard antidepressant titration considerations.

Telehealth-delivered CBT

Critical for severely housebound patients who cannot attend in-person therapy as a starting point. Video-delivered CBT has accumulated evidence comparable to in-person for many anxiety disorders. Beginning treatment from home and working up to in-person exposure as the agoraphobic pattern softens is often the only realistic sequence for severe cases.

Home-visit or community-based therapy

Therapist meets the patient in their home initially, then in graduated outdoor settings. Less commonly available but has trial evidence; community mental health programs in some regions offer this. Useful for patients too impaired to begin even telehealth-delivered CBT.

Benzodiazepines (limited role)

Short-term bridge while SSRI takes effect, or as-needed for an unavoidable feared situation early in treatment. Not appropriate for daily long-term use because they impede the extinction learning that exposure-based treatment depends on — taking a benzodiazepine before each feared exposure prevents the underlying habituation. Use with restraint.

Group exposure therapy

For patients with significant social anxiety or isolation alongside agoraphobia, group format adds an interpersonal dimension and a built-in source of accountability. The group itself can become a graduated exposure (initially feared, eventually safe).

Is agoraphobia the same as being afraid of crowds?

No. Agoraphobia in DSM-5-TR requires fear of two or more of FIVE situation types: public transit, open spaces, enclosed spaces, standing in line or in crowds, and being outside home alone. Crowd-only fear meeting just that one criterion is more appropriately classified as specific phobia (situational type). The "two or more" criterion captures the broader avoidance pattern characteristic of true agoraphobia.

Do I have agoraphobia if I have panic attacks in stores?

Not necessarily. Many patients with panic disorder experience attacks in specific situations without developing the broader avoidance pattern of agoraphobia. Agoraphobia requires marked fear of two or more agoraphobic situation types and active avoidance or distress in them, persisting 6+ months. A clinical interview distinguishes panic-with-situational-avoidance from formal agoraphobia.

I can't leave the house to see a therapist. What do I do?

Telehealth-delivered CBT is the realistic starting point for severely housebound patients. Beginning treatment from home and working up to in-person exposure as the agoraphobic pattern softens is often the only viable sequence. SSRIs can also be started via telehealth psychiatric care. Some regions have home-visit therapists or mobile crisis teams for very severe cases.

Can ketamine help me leave my house?

The evidence base in agoraphobia specifically is small but the broader anxiolytic mechanism may help — particularly for patients whose agoraphobia is severe enough to prevent exposure-CBT engagement. Pairing ketamine sessions with concurrent telehealth-delivered exposure work leverages the post-session window. Tovani's at-home model makes ketamine accessible to patients who cannot attend an in-clinic program.

Will I have to do exposure therapy?

For durable change, yes — extinction-learning from systematic exposure is the mechanism that produces lasting reduction in agoraphobic avoidance. Medications (including ketamine) can lower baseline anxiety enough to make exposure tolerable, but cannot replace the underlying experiential learning. The exposure can be graduated, telehealth-supported, and paced to your tolerance.